Insider Transactions in Q1 2022 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
2,158
-1.32%
|
$0
$0.82 P/Share
|
|
Jan 14
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,611
-1.04%
|
$0
$0.82 P/Share
|
|
Jan 13
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
2,563
-1.55%
|
$0
$0.81 P/Share
|
|
Jan 13
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,471
-1.0%
|
$0
$0.81 P/Share
|
|
Jan 11
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
4,722
-2.77%
|
$0
$0.87 P/Share
|
|
Jan 11
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,740
-2.53%
|
$0
$0.87 P/Share
|
|
Jan 10
2022
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.51%
|
-
|
|
Jan 10
2022
|
Michael H. Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+23.78%
|
-
|
|
Jan 10
2022
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.97%
|
-
|
|
Jan 10
2022
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.18%
|
-
|
|
Jan 10
2022
|
Steven S Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+23.56%
|
-
|
|
Jan 10
2022
|
Peter G Traber Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.49%
|
-
|
|
Jan 10
2022
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+26.38%
|
-
|
|
Jan 10
2022
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,694
-2.35%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
64,500
+16.48%
|
-
|
|
Jan 10
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
17,405
-9.27%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
BUY
Grant, award, or other acquisition
|
Direct |
129,000
+40.74%
|
-
|
|
Jan 10
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,410
-7.86%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
401,000
+35.86%
|
-
|